Hongyan Zhang

机构：Qinghai University, Tongji University, University of Science and Technology of China, Jiangxi University of Water Resources and Electric Power, Yunnan University, Anhui Medical University, Renji Hospital, Hefei University, Fudan University Shanghai Cancer Center, First Affiliated Hospital of Jiangxi Medical College, Hefei CAS Ion Medical and Technical Devices (China), Nanchang Institute of Science & Technology, Center for Life Sciences · ORCID：0000-0001-6424-3261

发表论文 589 篇 · 总被引 13406 次 · h-index 57

代表论文

• Portable devices and machine learning-assisted lateral flow assay for food safety analysis: Developments and perspectives (2025 · Trends in Food Science & Technology · 被引 11)
• Nanozyme-amplified lateral flow nanobody-immunoassay via PEI-mediated coupling strategy for sensitive detection of 3-phenoxybenzoic acid (2025 · Food Bioscience · 被引 5)
• A potent GalNAc-siRNA drug, RBD1016, leads to sustained HBsAg reduction and seroconversion in mouse models of HBV infection (2025 · Molecular Therapy — Nucleic Acids · 被引 5)
• Volatile compounds evaluation and characteristic aroma compounds screening in representative germplasm of mei (Prunus mume) based on metabolomics and sensomics (2025 · Food Chemistry · 被引 4)
• Neoadjuvant chemoradiotherapy with capecitabine and irinotecan guided by UGT1A1 status in patients with locally advanced rectal cancer: 5‐year update of the CinClare trial (2025 · 癌症：英文版 · 被引 3)
• RNA interference therapy targeting coagulation factor XI: a first-in-human trial of RBD4059 (vortosiran) (2026 · Blood Advances · 被引 2)